Latest filing published 06 Nov 2026 for Arovella Therapeutics Limited.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -24.2%Entry A$0.07 · Close 02 Nov 2026 A$0.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David John Williams: trading record in brief
David John Williams is a declared insider of Arovella Therapeutics Limited, with filings sourced from ASX. In total, 2 filings cover trades dated from 9 June 2026 to 5 November 2026.
The open-market record is one-sided, with 2 purchases worth €8,158 and not one sale. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 6 November 2026, reports an open-market purchase in Arovella Therapeutics Limited. Source: insider filings from ASX. Past trades are no guide to future returns.
Companies and markets linked to David John Williams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,000,000 sharesShareASXISIN AU0000182784ASX:2924-03158998-3A705982Canonical exit: 3 Feb 2027 (T+90)
- 200,000 shares@ A$0.0670.018% mcap100.0% of flowShareASXISIN AU0000182784ASX:2924-03098698-3A695000Canonical exit: 7 Sept 2026 (T+90)
2 of 2 declarations